Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Autosomal recessive spastic paraplegia type 32 (SPG32) is a rare, complex type of hereditary spastic paraplegia characterized by a slowly progressive spastic paraplegia (with walking difficulties appearing at onset at 6-7 years of age) associated with mild intellectual disability. Brain imaging reveals thin corpus callosum, cortical and cerebellar atrophy, and pontine dysraphia. The SPG32 phenotype has been mapped to a locus on chromosome 14q12-q21.
Features include always present findings: Mild intellectual disability, Pes cavus, and Difficulty walking (gait disturbance); and common findings: Babinski sign, Hypoplasia of the corpus callosum, Cerebellar cortical atrophy, and Abnormal pons morphology and others. 21 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 14 | Brain shrinkage (cerebral atrophy), Mild intellectual disability, Difficulty walking (gait disturbance) |
Biomarker and diagnostic research for hereditary spastic paraplegia 32 has been reported in the published literature.
Phenotype severity distribution: 3 always present features, 10 common features.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for hereditary spastic paraplegia 32.
19 publications have been identified in PubMed for hereditary spastic paraplegia 32. Research spans Case Report / Case Series (37%), Diagnostic / Biomarker (16%), and Epidemiology / Natural History (16%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 7 | 37% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 11:55 AM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Muscles | 4 | Brain shrinkage (cerebral atrophy), Shrinkage of the cerebellum (cerebellar atrophy), Lower limb muscle weakness |
Arms and legs | 4 | Lower limb spasticity, Lower limb muscle weakness, Lower limb hyperreflexia |
Testing and diagnosis research
3 |
16% |
Disease patterns and progression | 3 | 16% |
Clinical study results | 2 | 11% |
Laboratory research | 2 | 11% |
Other research | 1 | 5% |
Research summaries | 1 | 5% |
Roy S (2026). [PMID: 41006743](https://pubmed.ncbi.nlm.nih.gov/41006743/). *Acta Neurol Belg*. [Case Report / Case Series]
Malioukis A (2026). [PMID: 41772842](https://pubmed.ncbi.nlm.nih.gov/41772842/). *Neurocase*. [Case Report / Case Series]
Safka Brozkova D (2026). [PMID: 41749354](https://pubmed.ncbi.nlm.nih.gov/41749354/). *Hum Genomics*. [Diagnostic / Biomarker]
Yousaf H (2026). [PMID: 41673897](https://pubmed.ncbi.nlm.nih.gov/41673897/). *Hum Genomics*. [Review / Meta-Analysis]
Sallo FB (2025). [PMID: 39605873](https://pubmed.ncbi.nlm.nih.gov/39605873/). *Ophthalmol Sci*. [Diagnostic / Biomarker]
Quigley S (2025). [PMID: 39360554](https://pubmed.ncbi.nlm.nih.gov/39360554/). *Amyotroph Lateral Scler Frontotemporal Degener*. [Case Report / Case Series]
Penn D (2025). [PMID: 40470849](https://pubmed.ncbi.nlm.nih.gov/40470849/). *Mov Disord Clin Pract*. [Diagnostic / Biomarker]
O'Keefe E (2025). [PMID: 39760285](https://pubmed.ncbi.nlm.nih.gov/39760285/). *Eur J Neurol*. [Case Report / Case Series]
Nayan A (2025). [PMID: 40381180](https://pubmed.ncbi.nlm.nih.gov/40381180/). *Acta Neurol Belg*. [Other]
Shutoh A (2025). [PMID: 40797390](https://pubmed.ncbi.nlm.nih.gov/40797390/). *Medicine (Baltimore)*. [Case Report / Case Series]